As PARP1 was previously demonstrated to be associated with enhanced proliferation and enhanced DNA repair of cytotoxic agent-induced damage in OSCC, this suggests that the amplification-mediated increase in PARP1 and PARP2 expression in OSCC could potentially play a role in the development and progression of these tumours [51,190]. The gene discussed is PARP1; the disease is neoplasm.